Provided by Tiger Fintech (Singapore) Pte. Ltd.

IQVIA

152.32
+4.953.36%
Post-market: 152.740.4200+0.28%19:56 EDT
Volume:2.75M
Turnover:416.64M
Market Cap:26.35B
PE:20.74
High:152.34
Open:148.22
Low:147.62
Close:147.37
Loading ...

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
07 Jun

IQVIA Holdings Issues $2 Billion in Senior Notes

TIPRANKS
·
05 Jun

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
04 Jun

IQVIA Holdings Inc. Announces $2 Billion Senior Notes Offering

Reuters
·
02 Jun

IQVIA Announces Offering of Senior Notes

THOMSON REUTERS
·
02 Jun

IQVIA Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
29 May

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
28 May

BRIEF-Rein Therapeutics Announces First Patient Dosed In Renew Phase 2 Trial Of Lti-03 In Patients With Ipf

Reuters
·
27 May

Rein Therapeutics Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients With Ipf

THOMSON REUTERS
·
27 May

Rein Therapeutics Inc: Topline Interim Data From Renew Is Expected in First Half of 2026

THOMSON REUTERS
·
27 May

Redburn Atlantic Adjusts Price Target on IQVIA Holdings to $188 From $255, Maintains Buy Rating

MT Newswires Live
·
23 May

Iqvia price target lowered to $188 from $255 at Redburn Atlantic

TIPRANKS
·
23 May

IQVIA Holdings Inc. Stock Slips 5.3%, Underperforms Competitors

Dow Jones
·
22 May

IQVIA Holdings Is Maintained at Overweight by JP Morgan

Dow Jones
·
19 May

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
17 May

IQVIA Teams Up With SCRI to Expedite Development of New Cancer Therapies

MT Newswires Live
·
16 May

BRIEF-IQVIA And SCRI Collaborate To Accelerate Global Oncology Trials

Reuters
·
16 May

IQVIA and SCRI Team Up to Accelerate Global Oncology Trials

Reuters
·
16 May

IQVIA and Scri Collaborate to Accelerate Global Oncology Trials

THOMSON REUTERS
·
16 May

IQVIA Holdings Is Maintained at Outperform by Mizuho

Dow Jones
·
15 May